Hydrogen Therapy Turns Cold Tumors Hot to Fight Cancer Better

TL;DR

A new therapy using hydrogen-releasing nanoparticles can turn off cancer-supporting cells in tumors and boost the body's immune response to fight cancer.

Key Finding

Hydrogen therapy delivered through nanoparticles reversed cancer-promoting properties of tumor fibroblasts and enhanced immune cell activity against tumors in laboratory and mouse models.

Summary

This laboratory study examined how hydrogen gas, delivered through special nanoparticles made of magnesium and calcium carbonate, affects cancer-associated fibroblasts—cells in tumors that normally help cancer grow and hide from the immune system. Researchers found that hydrogen treatment reduced harmful molecules (reactive oxygen species) in these fibroblasts and changed them from tumor-promoting to tumor-fighting cells, which allowed immune cells called CD4+ T cells to work more effectively. When tested in mouse tumor models, this hydrogen therapy system slowed tumor growth and made "cold" tumors (those the immune system ignores) into "hot" tumors (those the immune system attacks).

Practical Takeaway

While this is early-stage laboratory research in cells and mice with no human trials yet, it suggests hydrogen gas may have potential in cancer immunotherapy by modifying the tumor's protective environment. However, this is far from clinical application, and much more research—including human studies—would be needed before any health claims could be made. The study does not provide evidence that hydrogen water would have similar effects.

Abstract (excerpt)

Tumor microenvironment (TME) plays an important role in the tumor progression. Among TME components, cancer-associated fibroblasts (CAFs) show multiple tumor-promoting effects and can induce tumor immune evasion and drug-resistance. Regulating CAFs can be a potential strategy to augment systemic…

Read the full abstract via DOI